Other Information
−Removed: No ne of our officers or directors, as defined in Rule 16a-1(f), adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended September 30, 2025.
+Added: No ne of our officers or directors, as defined in Rule 16a-1(f), adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Item 408 of Regulation S-K, during the three months ended March 31, 2026.
The following exhibits are incorporated by reference or filed or furnished as part of this report.
Incorporated by Reference Herein
−Removed: Form of Second Amended and Restated Deposit Agreement among Amarin Corporation plc, JPMorgan Chase Bank, N.A., as depositary (the “Depositary”), and all Holders and Beneficial Owners from time to time of American Depositary Receipts (“ADRs”) issued thereunder, including the Form of ADR attached as Exhibit A thereto
−Removed: Registration Statement on Form F-6, Exhibit (a)
−Removed: July 23, 2025
−Removed: Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated February 25, 2022*
−Removed: Current Report on Form 8-K as Exhibit 10.1
−Removed: October 22, 2025
−Removed: First Amendment to the Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated July 17, 2023*
−Removed: Current Report on Form 8-K as Exhibit 10.2
−Removed: October 22, 2025
−Removed: Second Amendment to the Employment Agreement, between David Keenan and Amarin Pharmaceuticals Ireland Limited, dated October 6, 2025*
+Added: Non-Employee Director Compensation Policy
Current Report on Form 8-K as Exhibit 10.1
−Removed: October 22, 2025
+Added: March 27, 2026
Certification of President and Chief Executive Officer (Principal Executive Officer) pursuant to Section 302 of Sarbanes-Oxley Act of 2002
Filed herewith
−Removed: Certification of Vice President and Global Controller (Principal Financial Officer and Principal Accounting Officer) pursuant to Section 302 of Sarbanes-Oxley Act of 2002
+Added: Certification of Senior Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) pursuant to Section 302 of Sarbanes-Oxley Act of 2002
Filed herewith
−Removed: Certification of President and Chief Executive Officer (Principal Executive Officer) and Vice President and Global Controller (Principal Financial Officer and Principal Accounting Officer) pursuant to Section 906 of Sarbanes-Oxley Act of 2002
+Added: Certification of President and Chief Executive Officer (Principal Executive Officer) and Senior Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) pursuant to Section 906 of Sarbanes-Oxley Act of 2002
Filed herewith
12 unchanged sentences
Filed herewith
−Removed: * Management contract or compensatory plan or arrangement.
−Removed: Certain personal information in this exhibit has been omitted in accordance with Regulation S-K Item 601(a)(6).
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
4 unchanged sentences
(On behalf of the Registrant)
−Removed: October 29, 2025
+Added: April 29, 2026
AMARIN CORPORATION PLC
4 unchanged sentences
(On behalf of the Registrant)
−Removed: October 29, 2025
+Added: April 29, 2026
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.